Work

Correction: Nelson et al. UGT1A1 Guided Cancer Therapy: Review of the Evidence and Considerations for Clinical Implementation. Cancers 2021, 13, 1566

Year: 2024

Type: erratum

Abstract: In the original publication [1], there was a mistake in Table 1 as published.In certain instances, UGT1A1 allele frequencies were inadvertently used to describe phenotype frequencies.The corrected Table 1 appears below.The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected.This correction was approved by the Academic Editor.

Source: Cancers

DOI: 10.3390/cancers16213595

Authors: Ryan S. Nelson, Nathan D. Seligson, Sal Bottiglieri, Estrella Carballido, Alex Del Cueto, Iman Imanirad, Richard Levine, Alexander S. Parker, Sandra M. Swain, Emma M. Tillman, J. Kevin Hicks

Institutions: Moffitt Cancer Center, ARUP Laboratories (United States), University of Florida, Nemours Children's Health System, Nemours Children's Clinic, University of South Florida, Georgetown University Medical Center, Indiana University School of Medicine

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,296

Funder: National Cancer Institute

Award: Moffitt Cancer Center Support Grant

OpenAlex ID: W4403774659

Cites: 1

Cited by: 8

Related to: 10